Proteoderm has used non-embryonic stem cells to develop a matrix of proteins (Matrix NC-138) used to harness the anti-aging potential in cosmeceutical products.
Proteonomix president Michael Cohen said the issuance of the INCI name will allow the company to move forward with commercialization of their NC-138 cosmeceutical product in the US.